SCHEMBL29577853

SCHEMBL29577853

c1ccc2c(Oc3cccc4ccccc34)cccc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1B P28222 5/20 0.54
ALDH1A1 P00352 7/20 0.50
KDM4E B2RXH2 4/20 0.50
HSD17B10 Q99714 4/20 0.50
TDP1 Q9NUW8 2/20 0.50
CYP2A6 P11509 2/20 0.50
TSHR P16473 2/20 0.50
HPGD P15428 2/20 0.50
KCNA3 P22001 1/20 0.50
GAA P10253 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
MAPT P10636 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
PGR P06401 1/20 0.48
PTGS1 P23219 1/20 0.48
MAPK1 P28482 1/20 0.48
HTR1D P28221 1/20 0.48
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
CYP1A2 P05177 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL442767 1.00 HTR1B (0.54) HTR1BALDH1A1KDM4EHSD17B10TDP1
Lithium SCHEMBL6571336 0.97 HTR1B (0.52) HTR1BALDH1A1KDM4EHSD17B10TDP1
Methane SCHEMBL10959030 0.97 HTR1B (0.52) HTR1BALDH1A1KDM4EHSD17B10TDP1
SCHEMBL7457103 0.97 HTR1B (0.52) HTR1BALDH1A1KDM4EHSD17B10TDP1
Ethane SCHEMBL10636467 0.95 HTR1B (0.50) HTR1BALDH1A1KDM4EHSD17B10TDP1
Ethylene SCHEMBL4726812 0.95 HTR1B (0.50) HTR1BALDH1A1KDM4EHSD17B10TDP1
SCHEMBL10540676 0.91 ALDH1A1 (0.51) HTR1BALDH1A1KDM4EHSD17B10TDP1
SCHEMBL441360 0.89 HPRT1 (0.61) HTR1BALDH1A1KDM4EHSD17B10TDP1
Ethylene Glycol SCHEMBL8646862 0.89 HTR1B (0.54) HTR1BALDH1A1KDM4EHSD17B10TDP1
Oxirane SCHEMBL11776735 0.89 HTR1B (0.46) HTR1BALDH1A1KDM4EHSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119431116-A Method for separating benzenediol isomer and 5-indenol from phenol-containing crude product 煤炭科学技术研究院有限公司 2025-02-14 CN claimed
US-12590048-B2 Dinaphthyl ether compound and lubricant composition containing same MORESCO CORPORATION (JP) 2026-03-31 US disclosed
US-20260001764-A1 METHOD FOR PRODUCING SULFIDE SOLID ELECTROLYTE IDEMITSU KOSAN CO.,LTD. (JP) 2026-01-01 US disclosed
US-20250388468-A1 METHOD FOR PRODUCING SULFIDE SOLID ELECTROLYTE IDEMITSU KOSAN CO.,LTD. (JP) 2025-12-25 US disclosed
EP-3633072-B1 HIGH-PURITY ELECTROLYTIC COPPER MITSUBISHI MATERIALS CORP (JP) 2025-07-30 EP disclosed
EP-4553861-A1 METHOD FOR PRODUCING SULFIDE SOLID ELECTROLYTE Idemitsu Kosan Co.,Ltd. (JP) 2025-05-14 EP disclosed
EP-4553862-A1 METHOD FOR PRODUCING SULFIDE SOLID ELECTROLYTE Idemitsu Kosan Co.,Ltd. (JP) 2025-05-14 EP disclosed
EP-4553860-A1 METHOD FOR PRODUCING SULFIDE SOLID ELECTROLYTE Idemitsu Kosan Co.,Ltd. (JP) 2025-05-14 EP disclosed
CN-119859380-A Resin composition 味之素株式会社 2025-04-22 CN disclosed
US-12258321-B1 Aryl-1,2,3-triazole compounds, pharmaceutical composition thereof and method for treatment of breast cancer University of Jeddah (SA) 2025-03-25 US disclosed
US-20240116841-A1 DINAPHTHYL ETHER COMPOUND AND LUBRICANT COMPOSITIONCONTAINING SAME MORESCO CORPORATION (JP) 2024-04-11 US disclosed
US-20240116841-A1 DINAPHTHYL ETHER COMPOUND AND LUBRICANT COMPOSITIONCONTAINING SAME MORESCO CORPORATION (JP) 2024-04-11 US disclosed
EP-4317102-A1 ADDITIVE FOR HYDRAULIC COMPOSITIONS, AND HYDRAULIC COMPOSITION USING SAME Osaka Gas Co., Ltd. (JP) 2024-02-07 EP disclosed
CN-117015522-A Dinaphthyl ether compound and lubricating oil composition containing the same 株式会社MORESCO 2023-11-07 CN disclosed
US-20230219983-A1 TETRADENTATE DIAMINODIPHOSPHINE LIGAND AND TRANSITION METAL COMPLEX, AND METHOD FOR MANUFACTURING SAME AND APPLICATION FOR SAME TAKASAGO INTERNATIONAL CORPORATION (JP) 2023-07-13 US disclosed
EP-3604319-B1 CATIONIC RUTHENIUM COMPLEX, AND PRODUCTION METHOD THEREFOR AND USE THEREOF TAKASAGO PERFUMERY CO LTD (JP) 2023-06-21 EP disclosed
US-11639362-B2 Tetradentate diaminodiphosphine ligand and transition metal complex, and method for manufacturing same and application for same TAKASAGO INTERNATIONAL CORPORATION (JP) 2023-05-02 US disclosed
WO-2022210972-A1 ADDITIVE FOR HYDRAULIC COMPOSITIONS, AND HYDRAULIC COMPOSITION USING SAME 大阪瓦斯株式会社 2022-10-06 WO disclosed
US-11453953-B2 High-purity electrolytic copper MITSUBISHI MATERIALS CORPORATION (JP) 2022-09-27 US disclosed
US-11325933-B2 Cationic ruthenium complex, and production method therefor and use thereof TAKASAGO INTERNATIONAL CORPORATION (JP) 2022-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219983-A1 TETRADENTATE DIAMINODIPHOSPHINE LIGAND AND TRANSITION METAL COMPLEX, AND METHOD FOR MANUFACTURING SAME AND APPLICATION FOR SAME ADH4, ADH5, PF4 HTR1B 2346/4885ALDH1A1 219/4885KDM4E 1294/4885
US-20260001764-A1 METHOD FOR PRODUCING SULFIDE SOLID ELECTROLYTE BRAF, JAK1, SAV1 HTR1B 3960/4885ALDH1A1 718/4885KDM4E 3173/4885
US-11639362-B2 Tetradentate diaminodiphosphine ligand and transition metal complex, and method for manufacturing same and application for same ADH4, ADH5, PF4 HTR1B 2346/4885ALDH1A1 219/4885KDM4E 1294/4885
US-20240116841-A1 DINAPHTHYL ETHER COMPOUND AND LUBRICANT COMPOSITIONCONTAINING SAME DERL1, UBE2L3, C9 HTR1B 390/4885ALDH1A1 545/4885KDM4E 1786/4885
US-20250388468-A1 METHOD FOR PRODUCING SULFIDE SOLID ELECTROLYTE JAK1, JAK2, SLC6A12 HTR1B 3108/4885ALDH1A1 932/4885KDM4E 3753/4885
US-12258321-B1 Aryl-1,2,3-triazole compounds, pharmaceutical composition thereof and method for treatment of breast cancer MCL1, BCL2, BCL2A1 HTR1B 562/4885ALDH1A1 1122/4885KDM4E 1969/4885
US-12590048-B2 Dinaphthyl ether compound and lubricant composition containing same MRE11, RAD51, MGLL HTR1B 2030/4885ALDH1A1 3157/4885KDM4E 1416/4885
US-11325933-B2 Cationic ruthenium complex, and production method therefor and use thereof NOTUM, POR, ADH1A HTR1B 1110/4885ALDH1A1 919/4885KDM4E 2570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.